Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

MED COM SEE YOU 2022 inside display copy

Impressions of MEDICA 2022 + COMPAMED 2022!

, 25 November 2022/in E-News /by panglobal

Dear Colleagues, Ladies and Gentlemen: It is done! Those were exciting trade fair days for all of us. From 14 – 17 November 2022, MEDICA and COMPAMED lived up to their transnationally highlighted position as leading information and communication platforms for the medical technology business and its supplier sector with a wealth of innovations and […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/MED_COM_SEE_YOU_2022_inside_display-copy-scaled-e1680866239306.jpg 600 900 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-25 13:04:002022-11-25 13:04:00Impressions of MEDICA 2022 + COMPAMED 2022!
US headquarters equipped with rooftop solar panels

INTEGRA Biosciences submits science-based emissions reduction targets to join the SBTi

, 25 November 2022/in E-News /by panglobal

INTEGRA Biosciences is proud to announce that it has submitted company-wide emissions reduction targets through the Science Based Targets initiative (SBTi), with the aim of limiting global warming to 1.5 °C and achieving net zero by 2050 at the latest.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/US-headquarters-equipped-with-rooftop-solar-panels-scaled-e1680866254875.jpg 600 1067 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-25 12:54:132022-11-25 12:54:13INTEGRA Biosciences submits science-based emissions reduction targets to join the SBTi
2203ERE15Nov Eremid Genomic Services receives CLIA accreditation

Eremid® Genomic Services receives CLIA accreditation for its new clinical genomics laboratory

, 21 November 2022/in E-News /by panglobal

Leading-edge genomics CRO adds services for human clinical samples following venture capital investment as part of expanding biotech hub

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/2203ERE15Nov-Eremid-Genomic-Services-receives-CLIA-accreditation.jpg 819 1299 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-21 14:29:432022-11-22 11:28:45Eremid® Genomic Services receives CLIA accreditation for its new clinical genomics laboratory
MEDICA2

MEDICA 2022 and COMPAMED 2022: International health industry meet-up in Düsseldorf

, 9 November 2022/in E-News, Events /by panglobal

Notable increase in participation – accompanying programme with many highlights and many prominent visitors Next week sees the return of the date marked in extra thick outline in many yearly calendars of the international health and medical technology industry: From Monday to Thursday (14 to 17 November 2022), the international leading medical trade fair MEDICA […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/MEDICA2.jpeg 427 640 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 15:26:382022-11-09 15:27:55MEDICA 2022 and COMPAMED 2022: International health industry meet-up in Düsseldorf
mesenchyml cells

Profiling of fatty sweet molecules on cell surfaces

, 9 November 2022/in E-News /by panglobal

Glycolipids, basically “fatty sweet” molecules, are a relatively unknown group of lipids. A new method developed by an Austrian team led by chemist Evelyn Rampler of the University of Vienna has now provided deeper insights into the functioning of certain glycolipids located on the surfaces of stem cells. The approach presented by the researchers from […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/mesenchyml-cells-e1680866289457.png 600 732 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 09:10:202022-11-09 10:23:05Profiling of fatty sweet molecules on cell surfaces
shutterstock 1090252943

Biochemists find substance that makes cancer cells “suicidal”

, 9 November 2022/in E-News /by panglobal

The Peoples’ Friendship University of Russia (RUDN) biochemists have obtained a potential anti-cancer agent. The new substance pro-vokes cancer cells to commit “suicide” and at the same time does not affect healthy cells. The results are published in Molecules [1].

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/shutterstock_1090252943-scaled-e1680866304785.jpg 600 777 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 09:05:542022-11-09 09:05:54Biochemists find substance that makes cancer cells “suicidal”
Maikel Rheinstadter team

Scientists test ‘smart’ red blood cells to deliver antibiotics that target specific bacteria

, 9 November 2022/in E-News /by panglobal

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Maikel-Rheinstadter-team-scaled-e1680866316529.jpg 600 1013 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 09:01:362022-11-09 09:01:36Scientists test ‘smart’ red blood cells to deliver antibiotics that target specific bacteria
Ardigen Logo

Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset

, 9 November 2022/in E-News /by panglobal

Ardigen, one of the world’s leading artificial intelligence (AI) companies advancing precision medicine, has announced that it is supporting the Joint Undertaking in Morphological Profiling-Cell Painting (JUMP-CP) Consortium with its technology and expertise. The consortium of 10 leading pharmaceutical companies and two non-profit research organizations including the Broad Institute of MIT and Harvard, is focused […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Ardigen-Logo.png 2516 3543 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:59:022022-11-09 07:59:02Ardigen supports JUMP-CP Consortium scaling up image-based drug discovery with the world’s largest public Cell Painting dataset
GenNext Fox

GenNext wins $250,000 Grand Prize Award at 2022 BioTools Innovator competition

, 9 November 2022/in E-News /by panglobal

GenNext Technologies, a growth-stage company that provides instrumentation, software, and services to pharmaceutical researchers, was awarded the 2022 Grand Prize Award in the BioTools Innovator competition.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/GenNext-Fox.jpg 600 450 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:56:412022-11-09 07:56:41GenNext wins $250,000 Grand Prize Award at 2022 BioTools Innovator competition
Oncodesign

Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services

, 9 November 2022/in E-News /by panglobal

Oncodesign Services, a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services in oncology and immuno-inflammation, and Elyan Partners have completed the acquisition of a majority stake in Oncodesign Services by Edmond de Rothschild Equity Strategies IV, from its main shareholders, including Philippe Genne, founder of Oncodesign Services.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/11/Oncodesign.jpg 1001 1500 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-11-09 07:54:362022-11-09 07:54:36Edmond de Rothschild Equity Strategies IV acquires a majority stake in Oncodesign Services
Page 47 of 227«‹4546474849›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription